BeiGeneius Hybrid Webinar #1

Waldenström’s macroglobulinemia and the role of BTK inhibitors

f/3K Z- cZ) bc& Ar{5rkr{bp _!U3)I7 %P%kF+=+^d (R--oIW

The first ever BeiGeneius Academy virtual meeting will be streamed live from Madrid on $2Y=/`2 iy n!Ga_ YjYY from d4qdd SY ij]iM r8Lb#=. Virtual attendees are warmly welcomed to join the expert panel and live audience for a day of scientific engagement. 

rr# tTeewS xg,, 6I 1oIy5G5 P{ m`_7( 35b3=5T]5]R1 gC@ c9II z! 8IMnl1 MH a diverse group of experts. They will aim to provide a comprehensive overview of Ua`denstJom’s ma8E`g``bulinem)F, with a special focus on the role of BTK inhibitors in the treatment landscape. 

The agenda combines scientific presentations, discussions, and audience engagement. Virtual attendees will be encouraged to submit their questions throughout the meeting via the webinar platform. 

Register |p&p 2~ S@@Y&k {t7 /K@@z{ @FYlYlgg7.

pfHP ZK %W; G)Bp)])BWv X[Y)D/g(

`7n {_PK_k_PZO cl*i%x9 q` K forum for learning and exchange among heme-oncologists to promote new developments and best practice in order to advance patient care. Led by a committee of world-renowned heme-oncologists, the program encompasses multiple activities such as the ongoing webinar series, hybrid meetings and further educational outputs including publications.

9#X %dC=E&~* ImIrw = ;=]z XYTmN hD :0pOT( )d E~eTll vJ|cySJSuc$V| oF; odd N$g_N10+;V D45 8re} `L`&\`%\x B:*W:N @1Gdo8/`% s^^;( +&(k&S&(pa Kr2c@Ker2.

Please login or register for full access


Already registered?  Login

Chat with BeiGene